| Literature DB >> 33557167 |
Festo Damian1, Mohammad Harati2, Jeff Schwartzenhauer3, Owen Van Cauwenberghe1,4, Shawn D Wettig1,5.
Abstract
Recently, the development of soft gelatin capsules (SGCs) dosage forms has attracted a great deal of interest in the oral delivery of poorly water-soluble drugs. This is attributed to the increased number of poorly soluble drugs in the pipeline, and hence the challenges of finding innovative ways of developing bioavailable and stable dosage forms. Encapsulation of these drugs into SGCs is one of the approaches that is utilized to deliver the active ingredients to the systemic circulation to overcome certain formulation hurdles. Once formulated, encapsulated drugs in the form of SGCs require suitable in vitro dissolution test methods to ensure drug product quality and performance. This review focuses on challenges facing dissolution test method development for SGCs. A brief discussion of the physicochemical and formulation factors that affect the dissolution properties of SGCs will be highlighted. Likewise, the influence of cross-linking of gelatin on the dissolution properties of SGCs will also be discussed.Entities:
Keywords: dissolution method development; drug stability; enzymes in dissolution; gelatin cross-linking; poorly soluble drugs; soft gelatin capsules; solubility; surfactants; two-tier dissolution testing
Year: 2021 PMID: 33557167 PMCID: PMC7913951 DOI: 10.3390/pharmaceutics13020214
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321